The nomination period for the upcoming ASCO Election is now closed. ASCO staff will review recommendations to confirm eligibility of submitted names. Following the eligibility check, the ASCO ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

ASCO is committed to fostering future leaders in the oncology community, offering a range of opportunities for oncology professionals at various career stages to build leadership skills throughout ...

ASCO supports oncology trainees and early career oncologists with specialized membership options: FREE Member-in-Training membership: Available to oncology trainees Discounted Full Member dues: ...

Individual presentation times are noted in your formal invitation and on the Speaker Center website. A question-and-answer panel will be held for all session participants at the end of the ...

ALEXANDRIA, Va. – The global oncology community will gather in Chicago and online to discuss the latest cutting-edge cancer research at the 2026 American Society of Clinical Oncology (ASCO) Annual ...

The ASCO late-breaking data policy allows for the submission of practice-changing late-breaking data for which no preliminary data are available at the time of the abstract submission deadline ...

Conquer Cancer®, the ASCO Foundation and Pfizer Inc. are collaborating to offer a Quality Improvement grant funding opportunity for healthcare systems, hospitals, cancer centers and other patient care ...

The 2025 ASCO Annual Meeting begins in just nine days, and we look forward to seeing you in Chicago. As you plan your schedule, consider joining the Association for Clinical Oncology’s advocacy events ...

ASCO is urging lawmakers to ensure America continues to lead in research through continued bipartisan support for federal health agencies and the scientists driving daily progress. Ahead of the April ...

Several presidential appointees have been confirmed to lead key health agencies that the Association for Clinical Oncology (ASCO) will work with during the new administration. These include: Robert F.